|
US3939159A
(en)
*
|
1974-05-29 |
1976-02-17 |
American Hoechst Corporation |
Spiro(pyrrolo (1,2-A)quinoxalines)
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4160452A
(en)
|
1977-04-07 |
1979-07-10 |
Alza Corporation |
Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
EP0247091B1
(en)
|
1985-11-01 |
1993-09-29 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
US5169645A
(en)
|
1989-10-31 |
1992-12-08 |
Duquesne University Of The Holy Ghost |
Directly compressible granules having improved flow properties
|
|
US5582837A
(en)
|
1992-03-25 |
1996-12-10 |
Depomed, Inc. |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
ATE173159T1
(de)
|
1992-03-25 |
1998-11-15 |
Depomed Systems Inc |
Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
|
|
DE4228095A1
(de)
*
|
1992-08-24 |
1994-03-03 |
Asta Medica Ag |
Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
|
|
WO1997047285A1
(en)
|
1996-06-10 |
1997-12-18 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
ES2248908T7
(es)
|
1997-06-06 |
2014-11-24 |
Depomed, Inc. |
Formas de dosificación de fármacos por vía oral y retención gástrica para liberación continuada de fármacos altamente solubles
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
US6323219B1
(en)
|
1998-04-02 |
2001-11-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods for treating immunomediated inflammatory disorders
|
|
NZ518739A
(en)
|
1999-11-02 |
2004-12-24 |
Depomed Inc |
Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
|
|
PT1251832E
(pt)
|
2000-02-04 |
2007-01-31 |
Depomed Inc |
Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
|
|
AU2000273378A1
(en)
|
2000-02-18 |
2001-08-27 |
Millennium Pharmaceuticals, Inc. |
Therapeutic methods that target fractalkine or cx3cr1
|
|
US20020010125A1
(en)
|
2000-03-16 |
2002-01-24 |
Carson Dennis A. |
Assay for agents that induce chemokinesis
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
US6451808B1
(en)
|
2000-10-17 |
2002-09-17 |
Depomed, Inc. |
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
|
|
US20030031711A1
(en)
|
2001-05-29 |
2003-02-13 |
Fara John W. |
Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough
|
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
JP2005508358A
(ja)
|
2001-10-25 |
2005-03-31 |
デポメド・インコーポレイテッド |
胃滞留型ロサルタン投与量を用いる治療方法
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
WO2003052082A2
(en)
|
2001-12-18 |
2003-06-26 |
Whitehead Institute For Biomedical Research |
Fusion partner cells and uses thereof
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
DE10228103A1
(de)
|
2002-06-24 |
2004-01-15 |
Bayer Cropscience Ag |
Fungizide Wirkstoffkombinationen
|
|
WO2004045526A2
(en)
|
2002-11-15 |
2004-06-03 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
|
|
WO2005033115A1
(en)
*
|
2003-10-07 |
2005-04-14 |
Astrazeneca Ab |
New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
|
|
US20060003020A1
(en)
*
|
2004-03-11 |
2006-01-05 |
The Regents Of The University Of Michigan |
Anti-metastatic ability of mibefradil and gadolinium
|
|
US20060115834A1
(en)
*
|
2004-10-19 |
2006-06-01 |
University Of Iowa Research Foundation |
Methods of identifying metastatic potential in cancer
|
|
UA90707C2
(en)
|
2005-04-06 |
2010-05-25 |
Астразенека Аб |
Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
|
|
TW200801513A
(en)
|
2006-06-29 |
2008-01-01 |
Fermiscan Australia Pty Ltd |
Improved process
|
|
RU2437889C2
(ru)
|
2006-09-29 |
2011-12-27 |
Астразенека Аб |
НОВЫЕ 5,7-ДИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ [1,3]ТИАЗОЛО[4,5-d]ПИРИМИДИН-2-(3Н)-АМИНА И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ
|
|
KR20140139125A
(ko)
*
|
2007-08-31 |
2014-12-04 |
퍼듀 퍼머 엘피 |
치환-퀴녹살린-형 피페리딘 화합물 및 그의 용도
|
|
EP2262778B8
(en)
*
|
2008-03-07 |
2020-01-01 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. |
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
|
|
AR071036A1
(es)
|
2008-03-26 |
2010-05-19 |
Astrazeneca Ab |
Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1.
|
|
JP5351254B2
(ja)
*
|
2008-05-23 |
2013-11-27 |
ノバルティス アーゲー |
キノキサリン−およびキノリン−カルボキシアミド誘導体
|
|
MX2011002636A
(es)
*
|
2008-09-11 |
2011-04-05 |
Chemocentryx Inc |
4-amino-3-(imidazoil)-pirazolo[3,4-d]pirimidinas.
|
|
JP2011127042A
(ja)
|
2009-12-18 |
2011-06-30 |
Fujifilm Corp |
アゾ顔料、アゾ顔料の製造方法、アゾ顔料を含む分散物、及び着色組成物
|
|
US8785490B2
(en)
*
|
2010-04-09 |
2014-07-22 |
University Of Louisville Research Foundation, Inc. |
Compounds for treating disease, for administering, and for pharmaceutical compositions
|
|
US8435993B2
(en)
|
2010-12-07 |
2013-05-07 |
Philadelphia Health And Education Corporation |
Methods of inhibiting metastasis from cancer
|